Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction

Journal of Cellular Biochemistry

Volumn 113, Issue 6, 2012, Pages 1998-2008

  Kummer, Nicolas T ^a   Nowicki, Theodore S ^a   Azzi, Jean P ^b   Reyes, Ismael ^a   Iacob, Codrin ^b   Xie, Suqing ^a   Swati, Ismatun ^a   Darzynkiewicz, Zbigniew ^a   Gotlinger, Katherine H ^a   Suslina, Nina ^a   Schantz, Stimson ^a   Tiwari, Raj K ^a   Geliebter, Jan ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

5 HETE; ARACHIDONATE 5 LIPOXYGENASE; EXTRACELLULAR MATRIX; MATRIX METALLOPROTEINASE 9; PAPILLARY THYROID CARCINOMA; TUMOR INVASION

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; GELATINASE B; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA;

ADULT; AGED; ARACHIDONATE 5-LIPOXYGENASE; CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LIPOXYGENASE INHIBITORS; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA, MESSENGER; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84859611690     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24069     Document Type: Article

References (40)

1. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, Das R, Jett M, Mulshine JL,. 2001. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15 (11): 2007-2009.
2. Bednar M, Kraemer R, Abraham NG, Mullane KM,. 1987. Arachidonic acid monooxygenase and lipoxygenase activities in polymorphonuclear leukocytes. Biochem Pharmacol 36 (10): 1741-1747.
3. Bernhard EJ, Muschel RJ, Hughes EN,. 1990. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50 (13): 3872-3877.
4. Bokoch GM, Reed PW,. 1981. Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes. J Biol Chem 256 (11): 5317-5320.
5. Brash AR,. 2001. Arachidonic acid as a bioactive molecule. J Clin Invest 107 (11): 1339-1345.
6. Capodici C, Pillinger MH, Han G, Philips MR, Weissmann G,. 1998. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase- dependent pathway. J Clin Invest 102 (1): 165-175.
7. Chambers AF, Matrisian LM,. 1997. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89 (17): 1260-1270.
8. Di Pasquale M, Rothstein JL, Palazzo JP,. 2001. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas. Hum Pathol 32 (1): 24-30.
9. Ding XZ, Tong WG, Adrian TE,. 2003. Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer. Oncology 65 (4): 285-294.
10. Egeblad M, Werb Z,. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (3): 161-174.
11. Fabien N, Fusco A, Santoro M, Barbier Y, Dubois PM, Paulin C,. 1994. Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer 73 (8): 2206-2212.
12. Ghosh J,. 2003. Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase. Biochem Biophys Res Commun 307 (2): 342-349.
13. Ghosh J, Myers CE,. 1997. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235 (2): 418-423.
14. Goldyne ME, Burrish GF, Poubelle P, Borgeat P,. 1984. Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. J Biol Chem 259 (14): 8815-8819.
15. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D,. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271 (18): 10672-10680.
16. Hanaka H, Shimizu T, Izumi T,. 2002 Nuclear-localization-signal-dependent and nuclear-export-signal-dependent mechanisms determine the localization of 5-lipoxygenase. Biochem J 361 (Pt 3): 505-514.
17. Jakobsson PJ, Steinhilber D, Odlander B, Radmark O, Claesson HE, Samuelsson B,. 1992. On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc Natl Acad Sci USA 89 (8): 3521-3525.
18. Laemmli UK,. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (5259): 680-685.
19. Luo M, Jones SM, Peters-Golden M, Brock TG,. 2003. Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity. Proc Natl Acad Sci USA 100 (21): 12165-12170.
20. Luo M, Pang CW, Gerken AE, Brock TG,. 2004. Multiple nuclear localization sequences allow modulation of 5-lipoxygenase nuclear import. Traffic 5 (11): 847-854.
21. Marks F, Muller-Decker K, Furstenberger G,. 2000. A causal relationship between unscheduled eicosanoid signaling and tumor development: Cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 153 (1-3): 11-26.
22. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M,. 2005. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115 (4): 1068-1081.
23. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J,. 2001. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69 (6): 851-859.
24. Pires de Miranda M, Reading PC, Tscharke DC, Murphy BJ, Smith GL,. 2003. The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol 84 (Pt 9): 2459-2471.
25. Poeckel D, Funk CD,. 2010 The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res 86 (2): 243-253.
26. Randall RW, Eakins KE, Higgs GA, Salmon JA, Tateson JE,. 1980. Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Agents Actions 10 (6): 553-555.
27. Rasband WS,. 2011 ImageJ,. Bethesda, Maryland, USA: National Institutes of Health.
28. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK,. 2008. editors. SEER cancer statistics review, 1975-2005. National Cancer Institute, Bethesda. based on November 2007 SEER data submission, posted to the SEER web site, 2008 National Cancer Institute.
29. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL,. 1991. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142 (2): 257-265.
30. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M,. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (6484): 61-65.
31. Silverman ES, Du J, De Sanctis GT, Radmark O, Samuelsson B, Drazen JM, Collins T,. 1998. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am J Respir Cell Mol Biol 19 (2): 316-323.
32. Soumaoro LT, Iida S, Uetake H, Ishiguro M, Takagi Y, Higuchi T, Yasuno M, Enomoto M, Sugihara K,., 2006. Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol 12 (39): 6355-6360.
33. Stacey DW, Roudebush M, Day R, Mosser SD, Gibbs JB, Feig LA,. 1991. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6 (12): 2297-2304.
34. Stuve O, Dooley NP, Uhm JH, Antel JP, Francis GS, Williams G, Yong VW,. 1996. Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9. Ann Neurol 40 (6): 853-863.
35. Tong WG, Ding XZ, Adrian TE,. 2002. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 296 (4): 942-948.
36. Uhl J, Klan N, Rose M, Entian KD, Werz O, Steinhilber D,. 2002. The 5-lipoxygenase promoter is regulated by DNA methylation. J Biol Chem 277 (6): 4374-4379.
37. Vasko VV, Saji M,. 2007. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr Opin Oncol 19 (1): 11-17.
38. Westermarck J, Kahari VM,. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13 (8): 781-792.
39. Yang P, Chan D, Felix E, Madden T, Klein RD, Shureiqi I, Chen X, Dannenberg AJ, Newman RA,. 2006. Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot Essent Fatty Acids 75 (6): 385-395.
40. Zeng ZZ, Yellaturu CR, Neeli I, Rao GN,. 2002 5(S)- hydroxyeicosatetraenoic acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and phosphatidylinositol 3-kinase/Akt signaling, leading to induction of expression of basic fibroblast growth factor 2. J Biol Chem 277 (43): 41213-41219.